Online citations, reference lists, and bibliographies.
← Back to Search

Differential Expression Of Peroxiredoxins In Prostate Cancer: Consistent Upregulation Of PRDX3 And PRDX4

Anamika Basu, H. Banerjee, H. Rojas, Shannalee R. Martinez, Sourav Roy, Z. Jia, M. Lilly, M. De León, C. Casiano
Published 2011 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The peroxiredoxins (PRDXs) are emerging as regulators of antioxidant defense, apoptosis, and therapy resistance in cancer. Because their significance in prostate cancer (PCa) is unclear, we investigated their expression and clinical associations in PCa.
This paper references
[Antinuclear autoantibodies].
E. Röther (1995)
10.1016/S0090-4295(00)00791-3
Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival.
W. Sakr (2000)
10.1093/JNCI/93.5.388
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
R. Hoffman (2001)
10.1002/path.1042
Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma
V. Kinnula (2002)
10.1007/BF03402079
Nonredundant Antioxidant Defense by Multiple Two-Cysteine Peroxiredoxins in Human Prostate Cancer Cells
C. Shen (2002)
Peroxiredoxins in breast carcinoma.
P. Karihtala (2003)
10.1074/JBC.M407707200
Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria*
T. Chang (2004)
10.1002/ijc.20294
Peroxiredoxins, a novel protein family in lung cancer
Siri Lehtonen (2004)
10.2202/1544-6115.1027
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
G. Smyth (2004)
10.1089/ARS.2005.7.768
Peroxiredoxins, oxidative stress, and cell proliferation.
S. Immenschuh (2005)
10.1002/PROS.20112
Antinuclear autoantibodies in prostate cancer: Immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis
T. Daniels (2005)
10.1158/0008-5472.CAN-05-1948
Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
X. Ouyang (2005)
cancer : Immunity to LEDGF / p 75 , a survival protein highly expressed in prostate tumors and cleaved during apoptosis
D Wittschieber (2005)
Abate-Shen C. Loss-offunction of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis
X Ouyang (2005)
10.4046/TRD.2005.59.2.142
Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
J. Park (2005)
10.1016/S0022-5347(05)00659-2
Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer.
C. Quan (2006)
10.2174/138920207781386951
The role of stress proteins in prostate cancer.
A. So (2007)
10.1016/j.febslet.2007.07.011
Peroxiredoxin‐4 interacts with and regulates the thromboxane A2 receptor
P. Giguère (2007)
10.1016/J.CDP.2006.11.004
Earlier age at diagnosis: another dimension in cancer disparity?
S. Karami (2007)
10.1002/ijc.23016
Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis
J. Lin (2007)
10.1158/0008-5472.CAN-07-0651
Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation.
S. Park (2007)
10.1158/0008-5472.CAN-07-0783
Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor.
Chang Xia (2007)
10.1038/nrc2090
Inflammation in prostate carcinogenesis
A. D. Marzo (2007)
10.1080/10715760701579314
Increased expression of mitochondrial glycerophosphate dehydrogenase and antioxidant enzymes in prostate cancer cell lines/cancer
Subir K. Roy Chowdhury (2007)
10.1016/j.neulet.2007.12.068
Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+
S. Simoni (2008)
10.1111/j.1349-7006.2008.00912.x
Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high‐mobility group protein B1
M. Shiota (2008)
10.1158/0008-5472.CAN-07-5259
Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
B. Kumar (2008)
10.1158/1055-9965.EPI-08-0203
Explaining the Race Difference in Prostate Cancer Stage at Diagnosis
B. Jones (2008)
10.1158/0008-5472.CAN-07-2608
Tumor immunobiological differences in prostate cancer between African-American and European-American men.
Tiffany A. Wallace (2008)
10.1016/j.canlet.2009.04.043
Peroxiredoxins, a novel target in cancer radiotherapy.
B. Zhang (2009)
10.1158/1541-7786.MCR-08-0546
Prx1 Enhances Androgen Receptor Function in Prostate Cancer Cells by Increasing Receptor Affinity to Dihydrotestosterone
R. Chhipa (2009)
10.3892/OR_00000366
Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis.
Kiyoon Kim (2009)
10.1158/0008-5472.CAN-07-6817
Conserved gene expression programs integrate mammalian prostate development and tumorigenesis.
C. Pritchard (2009)
10.1002/pros.20983
Evidence for field cancerization of the prostate
L. Nonn (2009)
10.1016/j.canlet.2008.12.011
Oxidative stress in prostate cancer.
Lakshmipathi Khandrika (2009)
10.1016/j.febslet.2009.04.009
TNF‐related apoptosis‐inducing ligand suppresses PRDX4 expression
H. Wang (2009)
10.1186/1756-9966-28-93
Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma
M. Cha (2009)
10.1186/1476-4598-8-68
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75
Melanie Mediavilla-Varela (2009)
10.1038/emboj.2009.101
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
Juxiang Cao (2009)
10.3322/caac.20006
Cancer Statistics, 2009
A. Jemal (2009)
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by the stress oncoprotein LEDGF/ p75
M Mediavilla-Varela (2009)
10.1016/S8756-3452(09)79352-1
Cancer Statistics, 2009
L. Tanoue (2010)
10.1007/s12253-010-9270-x
Nuclear Grading Versus Gleason Grading in Small Samples Containing Prostate Cancer: A Tissue Microarray Study
D. Wittschieber (2010)
10.1016/j.ejca.2010.02.006
Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis.
Marjo Pylväs (2010)
10.1016/j.ghir.2009.12.002
Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
S. Kalla Singh (2010)



This paper is referenced by
10.3892/etm.2021.9870
MicroRNA-383 promotes reactive oxygen species-induced autophagy via downregulating peroxiredoxin 3 in human glioma U87 cells
Zhou Xu (2021)
10.3390/ijms222111415
The Cytotoxic Effect of Copper (II) Complexes with Halogenated 1,3-Disubstituted Arylthioureas on Cancer and Bacterial Cells
A. Chrzanowska (2021)
10.1016/j.cryobiol.2021.02.002
Peroxiredoxin 6 translocates to the plasma membrane of human sperm under oxidative stress during cryopreservation.
Ling Xin (2021)
10.1155/2020/8359860
PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer In Vitro and In Vivo
Y. Chen (2020)
10.1155/2020/8262730
Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis
Jianbo Zheng (2020)
Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation.
Jianbo Zheng (2020)
10.1016/j.hbpd.2020.03.006
Therapeutic effect of hydrogen peroxide via altered expression of glutathione S-transferase and peroxiredoxin-2 in hepatocellular carcinoma.
Zehra Hashim (2020)
10.1080/09513590.2020.1768369
Suppression of PRDX4 inhibits cell proliferation and invasion of ectopic endometrial stromal cells in endometriosis
Yong Luo (2020)
10.1021/acs.jproteome.9b00587
Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer.
A. Mantsiou (2020)
10.1177/1533033819864313
PRDX4 and Its Roles in Various Cancers
W. Jia (2019)
10.1016/j.tranon.2018.11.014
Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis1
K. Tiedemann (2018)
10.3390/antiox8010011
Peroxiredoxins in Cancer and Response to Radiation Therapies
T. Forshaw (2019)
10.1111/1759-7714.13052
Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential
Zhenkun Liu (2019)
10.1136/jclinpath-2019-206173
PRDX3 is associated with metastasis and poor survival in uveal melanoma
P. Ramasamy (2019)
10.15430/JCP.2019.24.2.65
The Role of Peroxiredoxin Family in Cancer Signaling
Yosup Kim (2019)
10.1155/2018/2864120
Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma
T. Falcon (2018)
10.3390/ijms19124056
Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis
Sunny Trivedi (2018)
10.1186/s12864-018-4517-0
Liver proteome response of pre-harvest Atlantic salmon following exposure to elevated temperature
Waldo G. Nuez-Ortín (2018)
Role of ncRNAs in Hepatocellular Carcinoma
J. Zhao (2018)
The Role of Glucocorticoid Signaling in Prostate Cancer Health Disparities
Leanne W. Burnham (2018)
10.12659/MSM.908736
Peroxiredoxin 1 (PRDX1) Suppresses Progressions and Metastasis of Osteosarcoma and Fibrosarcoma of Bone
Yongxiang Wang (2018)
10.1042/BSR20180667
The prognostic values of the peroxiredoxins family in ovarian cancer
(2018)
10.1089/ars.2017.7422
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer.
M. Hampton (2017)
10.18632/oncotarget.17927
Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation.
Min-Yao Jiang (2017)
10.1186/s12967-017-1357-7
Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer
Z. Lv (2017)
10.1155/2017/4893921
Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes
Jaroslaw Szczyrba (2017)
10.3389/fcell.2017.00065
New Challenges to Study Heterogeneity in Cancer Redox Metabolism
R. Benfeitas (2017)
10.1111/jcmm.12955
Peroxiredoxin 1 – an antioxidant enzyme in cancer
Chenbo Ding (2016)
Proteomic and phenotypic approaches to assess nutritional physiology in Atlantic salmon
Wg Nuez-Ortin (2017)
10.1371/journal.pone.0183122
Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients
S. Khan (2017)
10.3892/mco.2017.1129
The role of peroxiredoxins in cancer
A. Nicolussi (2017)
10.1002/pros.23437
The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre‐clinical models
Leanne Woods-Burnham (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar